Lv1
40 积分 2025-03-11 加入
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
3天前
已完结
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes
12天前
已完结
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide
18天前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
23天前
已完结
Prediabetes and ischemic stroke
23天前
已关闭
Stroke in the Patient with Type 2 Diabetes
23天前
已关闭
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
26天前
已完结
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
26天前
已完结
Glucagon-like peptide 1 in health and disease
26天前
已完结
皖公网安备34019202002308
